“Safety Assessment of Dose-Escalated 225Ac-PSMA-617 Radioligand Therapy in Patients With Advanced Metastatic Castration-Resistant Prostate Cancer Following Standard Treatment Failure”. Voprosy Onkologii, vol. 71, no. 5, Nov. 2025, p. OF-2520, https://doi.org/10.37469/0507-3758-2025-71-5-OF-2520.